5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase
Bamborough, P., Christopher, J.A., Cutler, G.J., Dickson, M.C., Mellor, G.W., Morey, J.V., Patel, C.B., Shewchuk, L.M.(2006) Bioorg Med Chem Lett 16: 6236-6240
- PubMed: 16997559 
- DOI: https://doi.org/10.1016/j.bmcl.2006.09.018
- Primary Citation of Related Structures:  
2I40 - PubMed Abstract: 
The identification and hit-to-lead exploration of a novel, potent and selective series of substituted benzimidazole-thiophene carbonitrile inhibitors of IKK-epsilon kinase is described. Compound 12e was identified with an IKK-epsilon enzyme potency of pIC(50) 7.4, and has a highly encouraging wider selectivity profile, including selectivity within the IKK kinase family.
Organizational Affiliation: 
GlaxoSmithKline R&D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK.